Data Quality Review refers to the systematic process of examining and evaluating the accuracy, completeness, and reliability of data collected during clinical trials. This critical step ensures that the data used for analysis and decision-making meets predetermined quality standards and regulatory requirements.
The review typically involves checking for inconsistencies, missing information, and potential errors in the collected data. It may include comparing source documents with entered data, verifying adherence to the study protocol, and assessing the overall integrity of the dataset to support the validity of the clinical trial results.
Data Quality Review is crucial in clinical research as it ensures the integrity and reliability of study results. By identifying and correcting errors or inconsistencies in the data, it helps maintain the scientific validity of clinical trials and supports informed decision-making in drug development and patient care.
Furthermore, Data Quality Review is essential for regulatory compliance and the acceptance of clinical trial data by health authorities. It enhances the credibility of research findings, reduces the risk of drawing incorrect conclusions, and ultimately contributes to the safety and efficacy of new medical treatments.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2026 Axcellant